We hypothesized that, in comparison to non-diabetic individuals, those with T2D would present attenuated PEH as a consequence of reduced activity and release of vasodilator substances that compose the kallikrein-kinin system, such as PKA, BK and its metabolite (DesArg9-BK) as well as NO. Here, KLK4 is linked to type 2 diabetes mellitus.